This article was originally published in The Gray Sheet
ICD Registry Working Group will hold meetings through Nov. 30 to generate recommendations for CMS on designing and implementing a national registry of implantable cardioverter defibrillators. The registry will be created as a condition of CMS' proposed ICD coverage decision, issued Sept. 28. Under the decision, participation in a national ICD registry is required for reimbursement. Representatives from the Heart Rhythm Society will lead the group, which also includes reps from St. Jude Medical, Guidant, Medtronic, the American College of Cardiology, the Heart Failure Society of America, Duke Clinical Research Institute, University of Pittsburgh and Indiana University...
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.